Proteome research
Biognosys has raised €4.4M across 1 funding round, most recently a Series C round in Jul 2017. Based in Switzerland; active in Healthtech. Acquired by Bruker Corporation in 2023. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-07-04 | Series C | €4.4M | — | View deal → |
